Cargando…
Laparoscopic RFA with splenectomy for hepatocellular carcinoma
BACKGROUND: The treatment of hepatocellular carcinoma (HCC) is complicated and challenging because of the frequent presence of cirrhosis. Therefore, we propose a novel surgical approach to minimize the invasiveness and risk in patients with HCC, hypersplenism, and esophagogastric varices. METHODS: T...
Autores principales: | Hu, Kunpeng, Lei, Purun, Yao, Zhicheng, Wang, Chenhu, Wang, Qingliang, Xu, Shilei, Xiong, Zhiyong, Huang, He, Xu, Ruiyun, Deng, Meihai, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963946/ https://www.ncbi.nlm.nih.gov/pubmed/27464949 http://dx.doi.org/10.1186/s12957-016-0954-x |
Ejemplares similares
-
Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021) -
Mammalian‐enabled (MENA) protein enhances oncogenic potential and cancer stem cell‐like phenotype in hepatocellular carcinoma cells
por: Hu, Kunpeng, et al.
Publicado: (2017) -
The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis
por: Yang, Jiarui, et al.
Publicado: (2021) -
BDH2 is downregulated in hepatocellular carcinoma and acts as a tumor suppressor regulating cell apoptosis and autophagy
por: Liang, Hao, et al.
Publicado: (2019) -
Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
por: Xu, Jianliang, et al.
Publicado: (2019)